BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 9730698)

  • 21. [Angiotensin converting enzyme gene polymorphism and type 2 diabetic nephropathy].
    Liao L; Lei MX; Chen HL
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):553-6. PubMed ID: 15804059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
    Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M
    Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients.
    Arfa I; Abid A; Nouira S; Elloumi-Zghal H; Malouche D; Mannai I; Zorgati MM; Ben Alaya N; Rebai A; Zouari B; Ben Ammar S; Ben Rayana MC; Hmida S; Blousa-Chabchoub S; Abdelhak S
    J Renin Angiotensin Aldosterone Syst; 2008 Mar; 9(1):32-6. PubMed ID: 18404607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM.
    Doi Y; Yoshizumi H; Yoshinari M; Iino K; Yamamoto M; Ichikawa K; Iwase M; Fujishima M
    Diabetologia; 1996 Jan; 39(1):97-102. PubMed ID: 8720609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Angiotensin-converting enyme insertion/deletion polymorphism and blood pressure regulation in type 2 diabetic patients].
    Krajina-Andricević M; Zibar L; Glavas-Obrovac- L; Stefanić M; Avdicević M; Barbić J
    Acta Med Croatica; 2011 Oct; 65 Suppl 3():14-9. PubMed ID: 23120809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of the angiotensinogen M235T and angiotensin-converting enzyme insertion/deletion gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy.
    Eroglu Z; Cetinkalp S; Erdogan M; Kosova B; Karadeniz M; Kutukculer A; Gunduz C; Tetik A; Topcuoglu N; Ozgen AG; Tuzun M
    J Diabetes Complications; 2008; 22(3):186-90. PubMed ID: 18413162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin converting enzyme gene polymorphism and glomerular filtration rate changes in type 2 diabetic patients.
    Araz M; Okan V; Celen Z; Aynacioglu S
    Int J Clin Pract; 2002; 56(6):416-8. PubMed ID: 12166538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Association between ACE gene polymorphism and therapeutic responsiveness of ACEI in diabetic nephropathy].
    Wang L; Pan CY; Hu W
    Zhonghua Yi Xue Za Zhi; 1998 May; 78(5):372-4. PubMed ID: 10923445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ACE gene polymorphism and progression of diabetic nephropathy in Korean type 2 diabetic patients: effect of ACE gene DD on the progression of diabetic nephropathy.
    Ha SK; Park HC; Park HS; Kang BS; Lee TH; Hwang HJ; Kim SJ; Kim DH; Kang SW; Choi KH; Lee HY; Han DS
    Am J Kidney Dis; 2003 May; 41(5):943-9. PubMed ID: 12722028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control.
    Barnas U; Schmidt A; Illievich A; Kiener HP; Rabensteiner D; Kaider A; Prager R; Abrahamian H; Irsigler K; Mayer G
    Diabetologia; 1997 Mar; 40(3):327-31. PubMed ID: 9084972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus.
    Mizuiri S; Hemmi H; Inoue A; Yoshikawa H; Tanegashima M; Fushimi T; Ishigami M; Amagasaki Y; Ohara T; Shimatake H
    Nephron; 1995; 70(4):455-9. PubMed ID: 7477652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The significance of deletion polymorphism in the ACE gene for progression of diabetic nephropathies treated with ACE inhibitors].
    Tarnow L; Parving HH; Jacobsen P; Rossing P; Lecerf L; Poirier O; Cambien F
    Ugeskr Laeger; 1998 Aug; 160(34):4886-9. PubMed ID: 9741257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-I-converting enzyme insertion/deletion polymorphism and high urinary albumin concentration in French Type 2 diabetes patients.
    Hadjadj S; Gallois Y; Alhenc-Gelas F; Chatellier G; Marre M; Genes N; Lievre M; Mann J; Menard J; Vasmant D;
    Diabet Med; 2003 Aug; 20(8):677-82. PubMed ID: 12873298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM.
    Penno G; Chaturvedi N; Talmud PJ; Cotroneo P; Manto A; Nannipieri M; Luong LA; Fuller JH
    Diabetes; 1998 Sep; 47(9):1507-11. PubMed ID: 9726242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of insertion/deletion polymorphism in the ACE-I gene on the progression of diabetic glomerulopathy in type 1 diabetic patients with microalbuminuria.
    Rudberg S; Rasmussen LM; Bangstad HJ; Osterby R
    Diabetes Care; 2000 Apr; 23(4):544-8. PubMed ID: 10857950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM.
    Fujisawa T; Ikegami H; Shen GQ; Yamato E; Takekawa K; Nakagawa Y; Hamada Y; Ueda H; Rakugi H; Higaki J
    Diabetes Care; 1995 Jul; 18(7):983-5. PubMed ID: 7555560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ACE DD genotype is more susceptible than ACE II and ID genotypes to the antiproteinuric effect of ACE inhibitors in patients with proteinuric non-insulin-dependent diabetes mellitus.
    Ha SK; Yong Lee S; Su Park H; Ho Shin J; Jung Kim S; Hun Kim D; Rae Kim K; Yung Lee H; Suk Han D
    Nephrol Dial Transplant; 2000 Oct; 15(10):1617-23. PubMed ID: 11007831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of the association between a deletion polymorphism in the gene encoding angiotensin I-converting enzyme and advanced diabetic retinopathy.
    Matsumoto A; Iwashima Y; Abiko A; Morikawa A; Sekiguchi M; Eto M; Makino I
    Diabetes Res Clin Pract; 2000 Dec; 50(3):195-202. PubMed ID: 11106834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphism of the ACE Gene in dialysis patients: overexpression of DD genotype in type 2 diabetic end-stage renal failure patients.
    Park HC; Choi SR; Kim BS; Lee TH; Kang BS; Choi KH; Lee HY; Han DS; Ha SK
    Yonsei Med J; 2005 Dec; 46(6):779-87. PubMed ID: 16385653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin I converting enzyme gene polymorphism and diabetic nephropathy in type II diabetes.
    Schmidt S; Ritz E
    Nephrol Dial Transplant; 1997; 12 Suppl 2():37-41. PubMed ID: 9269698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.